Skip to main content

Generate Biomedicines, Inc 8-K, filed Nov 12, 2026

Generate Biomedicines, Inc. (GENB)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

Generate Biomedicines, Inc filed this 8-K on November 12, 2026.

Generate Biomedicines reported a $87.7 million net loss and $404.2 million in cash, cash equivalents, and marketable securities as of Sept. 30, 2026; it believes resources including $30.0 million from Zealand will fund its current operating plan into the first half of 2028. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits